137 related articles for article (PubMed ID: 7817479)
21. Decreased immunologic responsiveness following intensified vaginal immunization against urinary tract infection.
Uehling DT; Hopkins WJ; Balish E
J Urol; 1990 Jan; 143(1):143-5. PubMed ID: 2403596
[TBL] [Abstract][Full Text] [Related]
22. Minimal concentration of human IgM and IgG antibodies necessary to protect mice from challenges with live O6 Escherichia coli.
Massironi SM; Arslanian C; Carneiro-Sampaio MM; Pontes GN
FEMS Immunol Med Microbiol; 2011 Nov; 63(2):193-201. PubMed ID: 22077222
[TBL] [Abstract][Full Text] [Related]
23. Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains.
Hopkins WJ; Gendron-Fitzpatrick A; Balish E; Uehling DT
Infect Immun; 1998 Jun; 66(6):2798-802. PubMed ID: 9596750
[TBL] [Abstract][Full Text] [Related]
24. Opsonic activity of bovine serum and mammary secretion after Escherichia coli J5 vaccination.
Hogan JS; Todhunter DA; Tomita GM; Smith KL; Schoenberger PS
J Dairy Sci; 1992 Jan; 75(1):72-7. PubMed ID: 1541744
[TBL] [Abstract][Full Text] [Related]
25. Opsonic activity of serum and whey from cows immunized with the ferric citrate receptor.
Wise AJ; Hogan JS; Takemura K; Smith KL
J Dairy Sci; 2003 Jan; 86(1):146-51. PubMed ID: 12613859
[TBL] [Abstract][Full Text] [Related]
26. Studies of secretory antibodies to E. coli in human urine compared to the serum antibody content.
Hanson LA; Ahlstedt S; Carlsson B; Jodal U; Lindberg U; Sohl A
Adv Exp Med Biol; 1974; 45(0):399-408. PubMed ID: 4607111
[No Abstract] [Full Text] [Related]
27. Efficacy of intramammary immunization with an Escherichia coli J5 bacterin.
Smith JL; Hogan JS; Smith KL
J Dairy Sci; 1999 Dec; 82(12):2582-8. PubMed ID: 10629804
[TBL] [Abstract][Full Text] [Related]
28. Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein.
Roberts JA; Kaack MB; Baskin G; Chapman MR; Hunstad DA; Pinkner JS; Hultgren SJ
J Urol; 2004 Apr; 171(4):1682-5. PubMed ID: 15017266
[TBL] [Abstract][Full Text] [Related]
29. Systemic immunization with conserved pilus-associated adhesins protects against mucosal infections.
Palaszynski S; Pinkner J; Leath S; Barren P; Auguste CG; Burlein J; Hultgren S; Langermann S
Dev Biol Stand; 1998; 92():117-22. PubMed ID: 9554264
[TBL] [Abstract][Full Text] [Related]
30. Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response.
Verdonck F; Cox E; Van der Stede Y; Goddeeris BM
Vaccine; 2004 Oct; 22(31-32):4291-9. PubMed ID: 15474721
[TBL] [Abstract][Full Text] [Related]
31. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
[TBL] [Abstract][Full Text] [Related]
32. Experimental urinary tract infection in rabbits by a group D Streptococcus sp.: a study of serum immunoglobulin classes by enzyme-linked immunosorbent assay.
Desnottes JF; Fortier B; Bensman A; Ave-Virat A
Ann Microbiol (Paris); 1983; 134A(3):351-8. PubMed ID: 6416123
[TBL] [Abstract][Full Text] [Related]
33. Systemic and mucosal antibody responses to selected cell surface antigens of avian pathogenic Escherichia coli in experimentally infected chickens.
Kariyawasam S; Wilkie BN; Hunter DB; Gyles CL
Avian Dis; 2002; 46(3):668-78. PubMed ID: 12243531
[TBL] [Abstract][Full Text] [Related]
34. Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core.
Pollack M; Huang AI; Prescott RK; Young LS; Hunter KW; Cruess DF; Tsai CM
J Clin Invest; 1983 Dec; 72(6):1874-81. PubMed ID: 6358257
[TBL] [Abstract][Full Text] [Related]
35. [Urinary microflora and the status of local immunity in children with cystitis].
Sentsova TB; Bobkova VP; Iatsyk PK; Aiazbekov EA; Ulisko IN; Sarkisian AA
Pediatriia; 1990; (2):19-23. PubMed ID: 2190167
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity and protective efficacy of a single-dose live non-pathogenic Escherichia coli oral vaccine against F4-positive enterotoxigenic Escherichia coli challenge in pigs.
Fairbrother JM; Nadeau É; Bélanger L; Tremblay CL; Tremblay D; Brunelle M; Wolf R; Hellmann K; Hidalgo Á
Vaccine; 2017 Jan; 35(2):353-360. PubMed ID: 27916413
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of immunization with ferric citrate receptor FecA from Escherichia coli on induced coliform mastitis.
Takemura K; Hogan JS; Lin J; Smith KL
J Dairy Sci; 2002 Apr; 85(4):774-81. PubMed ID: 12018422
[TBL] [Abstract][Full Text] [Related]
38. [Effects of vaccination in urinary infections caused by Escherichia coli in rats].
Mathieu D; Jacques L; Auer J; Bizzini B
Biomed Pharmacother; 1987; 41(8):442-5. PubMed ID: 3330459
[TBL] [Abstract][Full Text] [Related]
39. Intestinal and serum antibody response in gnotobiotic piglets to oral immunization with Escherichia coli.
Dziaba KA; Lambrecht G; Petzoldt K
Comp Immunol Microbiol Infect Dis; 1985; 8(3-4):267-72. PubMed ID: 2419023
[TBL] [Abstract][Full Text] [Related]
40. [The study for the immuno-protection of E. coli O157:H7 outer membrane protein].
Zhang Y; Lu SQ; Zhang YZ; Zhao BX; Xu JG
Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):58-62. PubMed ID: 14990161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
